Joseph A Sowell Iii Hca Healthcare, Inc. (HCA) insider trading activity

Joseph A Sowell Iii is SVP; Chief Development Officer of HCA Healthcare, Inc.. Currently has a direct ownership of 13,367 shares of HCA, which is worth approximately $4.59 Million. The most recent transaction as insider was on May 15, 2024, when has been sold 9,908 shares (Common Stock) at a price of $326.96 per share, resulting in proceeds of $3,239,519. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 13.4K

212.68% 3M change

159.1% 12M change

Total Value Held $4.59 Million

Joseph A Sowell III Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
May 15 2024	SELL Payment of exercise price or tax liability	$3,239,519 $326.96 p/Share	9,908 Reduced 42.57%	13,367 Common Stock
May 15 2024	BUY Exercise of conversion of derivative security	$1,310,239 $68.96 p/Share	19,000 Added 44.94%	23,275 Common Stock
Feb 16 2024	SELL Payment of exercise price or tax liability	$618,642 $308.55 p/Share	2,005 Reduced 31.93%	4,275 Common Stock
Feb 16 2024	BUY Grant, award, or other acquisition	-	6,280 Added 50.0%	6,280 Common Stock
Nov 14 2023	SELL Bona fide gift	-	5,159 Reduced 100.0%	0 Common Stock
Feb 17 2023	SELL Payment of exercise price or tax liability	$641,592 $262.84 p/Share	2,441 Reduced 32.12%	5,159 Common Stock
Feb 17 2023	BUY Grant, award, or other acquisition	-	7,600 Added 50.0%	7,600 Common Stock

Oct 28 2022	SELL Open market or private sale	$2,889,288 $223.18 p/Share	12,946 Reduced 100.0%	0 Common Stock
Oct 25 2022	SELL Payment of exercise price or tax liability	$3,120,378 $214.4 p/Share	14,554 Reduced 52.92%	12,946 Common Stock
Oct 25 2022	BUY Exercise of conversion of derivative security	$1,319,175 $47.97 p/Share	27,500 Added 50.0%	27,500 Common Stock
Aug 10 2022	SELL Bona fide gift	-	17,051 Reduced 100.0%	0 Common Stock
Mar 11 2022	SELL Open market or private sale	$3,099,418 $269.0 p/Share	11,522 Reduced 40.32%	17,051 Common Stock
Feb 18 2022	SELL Payment of exercise price or tax liability	$743,529 $244.1 p/Share	3,046 Reduced 9.63%	28,573 Common Stock
Feb 18 2022	BUY Grant, award, or other acquisition	-	7,740 Added 19.67%	31,619 Common Stock
Jan 05 2022	SELL Payment of exercise price or tax liability	$3,069,571 $258.97 p/Share	11,853 Reduced 33.17%	23,879 Common Stock
Jan 05 2022	BUY Exercise of conversion of derivative security	$1,121,299 $47.97 p/Share	23,375 Added 39.55%	35,732 Common Stock
Jan 04 2022	SELL Open market or private sale	$5,754,388 $259.23 p/Share	22,198 Reduced 64.24%	12,357 Common Stock
Dec 29 2021	SELL Payment of exercise price or tax liability	$5,312,486 $258.49 p/Share	20,552 Reduced 37.29%	34,555 Common Stock
Dec 29 2021	BUY Exercise of conversion of derivative security	$1,589,445 $37.18 p/Share	42,750 Added 43.69%	55,107 Common Stock
Feb 18 2021	SELL Payment of exercise price or tax liability	$551,768 $174.61 p/Share	3,160 Reduced 20.36%	12,357 Common Stock
Feb 18 2021	BUY Grant, award, or other acquisition	-	10,147 Added 39.54%	15,517 Common Stock

JAS

Joseph A Sowell Iii

SVP; Chief Development Officer

Nashville, TN

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells HCA shares.

Notify only if

Value

Insider Trading

Get notified when an Hca Healthcare, Inc. insider buys or sells HCA shares.

Notify only if

Operation

Value

Type

News

Receive news related to HCA Healthcare, Inc.

Track Activities on HCA

Account